Merck Sues Over Medicare Drug-Price Negotiation Lawnews2023-06-06T18:41:33+00:00June 6th, 2023|The New York Times|
Samples of Popular Diabetes Drug Contain Potential Carcinogen, F.D.A. Saysnews2022-08-11T19:37:20+00:00August 11th, 2022|The New York Times|
Merck’s Covid Pill Is Authorized by F.D.A. for High-Risk Adultsnews2021-12-24T02:19:46+00:00December 24th, 2021|The New York Times|
Merck’s Covid Pill Might Pose Risks for Pregnant Womennews2021-12-13T15:27:03+00:00December 13th, 2021|The New York Times|
Los nuevos antivirales para la covid ofrecen esperanza frente a la variante ómicronnews2021-12-08T15:49:42+00:00December 8th, 2021|The New York Times|
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panelnews2021-12-01T00:23:13+00:00December 1st, 2021|The New York Times|
Antiviral Covid-19 Pills Are Coming. Will There Be Enough Tests?news2021-11-29T19:40:28+00:00November 29th, 2021|The New York Times|
U.S. to Buy Enough of Pfizer’s Covid Antiviral Pills for 10 Million Peoplenews2021-11-17T02:47:01+00:00November 17th, 2021|The New York Times|
Pfizer Says Its Antiviral Pill Is Highly Effective in Treating Covidnews2021-11-05T19:13:46+00:00November 5th, 2021|The New York Times|
U.K. Authorizes Merck’s Antiviral Pill for Covid-19news2021-11-04T17:42:59+00:00November 4th, 2021|The New York Times|